Navigation Links
Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
Date:5/13/2013

DUBLIN, May 13, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The events, presentation times and speakers include:

  • UBS Global Healthcare Conference in New York, NY on Tuesday, May 21, 2013 at 9:30 a.m. EDT/2:30 p.m. IST. Kathryn E. Falberg , executive vice president and chief financial officer, will provide a business update.
  • Jefferies 2013 Global Healthcare Conference in New York, NY on Tuesday, June 4, 2013 at 8:30 a.m. EDT/1:30 p.m. IST. Bruce C. Cozadd , chairman and chief executive officer, will provide a business update.
  • Lazard Capital Markets Conference Call at the 27th Annual Meeting of the American Academy of Sleep Medicine in Baltimore, MD on Wednesday, June 5, 2013 at 12:30 p.m. EDT/5:30 p.m. IST. Company management will discuss data being presented, including findings from the Burden of Narcolepsy Disease (BOND) study, and other business matters.

An archived version of each audio webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion and FazaClo® (clozapine, USP) HD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its EUSA Pharma division. For further information, see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
2. Arbor Pharmaceuticals Announces FDA Approval of First NDA
3. Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
4. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
5. Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
6. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
7. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
8. Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
9. The Zacks Analyst Blog Highlights: Exxon Mobil, Statoil, Chevron, Braskem and Cubist Pharmaceuticals
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BETHESDA, Md. , March 27, 2017  ImMAGE ... that its immunotherapy successfully passed early toxicology and efficacy ... immune system to target a specific protein, MAGE A, ... triple negative breast cancer. After 4 ... was able to show very little toxicity in a ...
(Date:3/27/2017)... SAN MATEO, Calif. , March 27, 2017 ... has been acquired by Ethicon, a division of ... Reflux Management System for the treatment of gastro-esophageal ... on magnetic sphincter augmentation (MSA) technology and the ... European medical centers. Torax Medical was ...
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... today announced the release of two biometric time and attendance tracking products: the ... 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition to enable ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... work, the Self-Funding Success website has recently developed and published an informational resource ... ” was created based on common inquiries the site’s team of third party ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... desire to achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) ... what dentists should be aware of when utilizing dental laboratories and technicians that ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to earn placements ... channels. , While many results are clear, much of PR is hard to quantify. ... it comes to measurement, firms should always take an all-inclusive approach that takes both ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Silicon Valley Hair ... to announce a new blog post about women’s hair loss. Although hair transplant procedures ... loss as they age. Menopause or genetics can be two reasons a woman may ...
Breaking Medicine News(10 mins):